A detailed history of Westside Investment Management, Inc. transactions in Lantern Pharma Inc. stock. As of the latest transaction made, Westside Investment Management, Inc. holds 30,650 shares of LTRN stock, worth $93,176. This represents 0.02% of its overall portfolio holdings.

Number of Shares
30,650
Previous 11,500 166.52%
Holding current value
$93,176
Previous $53.7 Million 109.46%
% of portfolio
0.02%
Previous 0.01%

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 20, 2024

BUY
$3.42 - $4.83 $65,493 - $92,494
19,150 Added 166.52%
30,650 $112 Million
Q2 2024

Jul 17, 2024

BUY
$3.91 - $9.51 $44,965 - $109,365
11,500 New
11,500 $53.7 Million

Others Institutions Holding LTRN

About Lantern Pharma Inc.


  • Ticker LTRN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 10,830,900
  • Market Cap $32.9M
  • Description
  • Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...
More about LTRN
Track This Portfolio

Track Westside Investment Management, Inc. Portfolio

Follow Westside Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Westside Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Westside Investment Management, Inc. with notifications on news.